M-tron Industries Inc (MPTI) FY Conference June 11, 2025 03:30 PM ET Speaker0 For joining us. Our next presentation is from Imtron Industries trading on the New York Stock Exchange under the tick ticker symbol MPTI. Speaking on behalf of the company today is their interim CEO and CFO, Cameron Forr, and president, Bill Drafts. Speaker1 Thank you. So thank you everybody for coming and your interest in learning about the company. Really appreciate it. And also a huge thank you to the three part advisors team. ...

Summary of Ascent Industries (ACNT) FY Conference Call - May 05, 2025 Company Overview - Ascent Industries is a 75-year-old industrial manufacturing company with two operating segments: Specialty Chemicals and Stainless Steel Tubular Assets [6][8] - The management team, including Brian and Ryan, has a history of successfully turning around companies, previously achieving a turnaround from a loss of $8 million to an adjusted EBITDA of $35 million at Clearon [4][5] Financial Performance - In 2024, Ascent Industries achieved a turnaround of approximately $20 million in adjusted EBITDA, with significant improvements in gross profit and working capital [9][10] - The company sold one of its stainless steel tubular holdings for $45 million, which is a 10% premium on book value [12][13] - Ascent currently has $55 million in cash on hand and aims to build a scalable, high-quality business [16][34] Strategic Focus - The company is in the final stages of a turnaround and portfolio optimization, with a focus on organic growth and the final divestiture of its remaining stainless steel asset [8][31] - Ascent aims to shift its product mix from 75% custom manufacturing and 25% branded products to a target of 65% branded products over time [20][46] - The total addressable market (TAM) for Ascent's branded products is approximately $9.2 billion, covering various sectors including oil and gas, personal care, and coatings [37][38] Market Dynamics - Ascent's competitive landscape is intense in custom manufacturing, but the company can compete effectively in the branded products space by targeting small to mid-tier customers [48][50] - The company is actively working on reshoring supply chains for critical ingredients, which is seen as a potential tailwind for future growth [45] Margin Improvement - The gross margin was improved from sub-10% to low teens, with a target of achieving gross margins of no less than 30% in the long term [24][26] - The company plans to maintain SG&A expenses at no higher than 15% and target adjusted EBITDA of around 15% [26] Capital Allocation and Growth Strategy - Ascent is considering share repurchases as an option but is focused on maintaining flexibility for organic and inorganic growth opportunities [55][60] - The company is selective in pursuing M&A opportunities, emphasizing the importance of not acquiring assets that could exacerbate existing underutilization issues [61][63] - The remaining tubular asset is expected to generate $4-6 million in adjusted EBITDA annually, with plans to divest it ideally within the year [64][66] Conclusion - Ascent Industries is positioned for growth with a strong balance sheet and a clear focus on enhancing its specialty chemicals business while optimizing its portfolio [34][35] - The management team is optimistic about the future, citing a disciplined approach to growth and a commitment to improving operational efficiency [70][72]

Financial Data and Key Metrics Changes - The company reported a 125% year-over-year increase in adjusted EBITDA, reaching $19.9 million, while gross profit increased by 1,349% to $20.5 million despite a top-line compression of $15.3 million or 7.9% [14][36] - For the fourth quarter, net sales from continuing operations were $40.7 million, slightly down from $41.2 million in the same quarter of 2023, with gross profit increasing to $7.3 million from a loss of $2.1 million [32][33] - The full-year net sales decreased to $177.9 million from $193.2 million in 2023, but gross profit rose significantly to $22.1 million from $1.5 million [36][37] Business Segment Data and Key Metrics Changes - In the tubular products segment, there was a year-over-year sales decline of $12.4 million, but segment-level gross profit increased by approximately $15 million due to cost management and product line optimization [16] - The specialty chemicals segment achieved its highest quarterly adjusted EBITDA since Q2 2022, driven by a 14% increase in gross margin despite moderate top-line compression [19][20] - Branded product sales in the specialty chemicals segment recorded a double-digit year-over-year increase, primarily driven by efforts in the oil and gas market [22] Market Data and Key Metrics Changes - The total addressable market for the specialty chemicals segment is over $9 billion, with a specific focus on branded products that offer faster cycle times and predictable demand [20] - The company noted a stronger order backlog in the tubular segment than it has seen in four years, indicating improving market dynamics [17] Company Strategy and Development Direction - The company plans to maximize the value of its assets in the tubular product segment while investing in profitable growth in the specialty chemicals segment [7][8] - There is a focus on organic growth within existing product portfolios and underutilized capabilities, with a commitment to high-potential strategic initiatives [25][24] - The company has expanded its stock repurchase program, allowing for the acquisition of up to an additional one million shares over the next 24 months [9] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's foundation and its ability to drive growth while maintaining operational excellence [8][10] - The outlook for top-line growth is more optimistic for the second half of 2025, with expectations of market share gains rather than market-driven growth [44] - Management highlighted the importance of domestic sourcing and supply chain optimization as a competitive advantage [57][58] Other Important Information - The company remains debt-free with $16 million in cash and $47 million available on its revolving credit facility, positioning it well for future investments [39] - A total of 101,263 shares were repurchased for approximately $1 million during the year [40] Q&A Session Summary Question: Where do you see top-line growth starting? - Management indicated that top-line growth is expected more in the second half of 2025, with any uptick likely due to market share gains rather than market recovery [44] Question: What contributed to the growth in cash from Q3 to Q4? - The increase in cash was primarily driven by optimizing idle inventory and improved cash conversion cycles [48][49] Question: Any updates on underutilized assets? - Management confirmed the sale of a smaller warehouse and mentioned ongoing efforts to find a permanent solution for other underutilized assets [52] Question: How is the new cleaning portfolio being accepted? - The reception was positive, with new opportunities being pursued following the launch at a cleaning conference [55] Question: Is there potential for further margin improvement in chemicals? - Management believes there is potential for ongoing margin improvement as branded product sales increase, although significant price increases are not anticipated for 2025 [61] Question: Is the share repurchase plan feasible? - Management stated that the plan provides optionality and is contingent on market conditions and share price [64] Question: Where do you see the company a year from now? - Management emphasized a pivot to growth, focusing on filling underutilized assets with high-value applications [68]